Abstract
Background and objectives
The molecular mechanisms regulating megakaryocytopoiesis and hemostasis remain largely unknown. The Tyro 3 subfamily of receptor tyrosine kinases (RTK), which is composed of three members (Tyro 3, Axl and Mer), plays important roles in various tissues, such as those in the nervous, immune and reproductive systems. Here, we investigate the roles of the Tyro 3 RTK subfamily in regulating megakaryocytopoiesis and hemostasis.Design and methods
Single, double, and triple knock-out mice for the three Tyro 3 RTK were used in the study. Bleeding time, platelet count, megakaryocyte count, megakaryocyte ploidy, rate of proplatelet formation, platelet aggregation and ATP release were used as criteria to evaluate hemostasis, megakaryocytopoiesis and platelet function.Results
Mice lacking all three receptors had impaired hemostasis and mild thrombocytopenia, which may be due to platelet dysfunction and defective megakaryocytopoiesis. Mice lacking different combinations of two receptors of the Tyro 3 RTK subfamily had normal platelet counts in peripheral blood, but exhibited impaired hemostasis and platelet function. Although knock-out mice for any single receptor had normal hemostasis and megakaryocytopoiesis, they exhibited a mild platelet dysfunction.Interpretation and conclusions
The Tyro 3 RTK subfamily plays important roles in regulating hemostasis, megakaryocytopoiesis and platelet function.Full text links
Read article at publisher's site: https://doi.org/10.3324/haematol.10939
Read article for free, from open access legal sources, via Unpaywall: https://haematologica.org/article/download/4436/15984
Citations & impact
Impact metrics
Citations of article over time
Article citations
MERTK Inhibition as a Targeted Novel Cancer Therapy.
Int J Mol Sci, 25(14):7660, 12 Jul 2024
Cited by: 0 articles | PMID: 39062902 | PMCID: PMC11277220
Review Free full text in Europe PMC
From MASH to HCC: the role of Gas6/TAM receptors.
Front Immunol, 15:1332818, 17 Jan 2024
Cited by: 4 articles | PMID: 38298195 | PMCID: PMC10827955
Review Free full text in Europe PMC
TAM family kinases as therapeutic targets at the interface of cancer and immunity.
Nat Rev Clin Oncol, 20(11):755-779, 04 Sep 2023
Cited by: 13 articles | PMID: 37667010
Review
Intrinsic and Extrinsic Control of Hepatocellular Carcinoma by TAM Receptors.
Cancers (Basel), 13(21):5448, 29 Oct 2021
Cited by: 7 articles | PMID: 34771611 | PMCID: PMC8582520
Review Free full text in Europe PMC
Megakaryocytic Expansion in Gilteritinib-Treated Acute Myeloid Leukemia Patients Is Associated With AXL Inhibition.
Front Oncol, 10:585151, 09 Dec 2020
Cited by: 3 articles | PMID: 33363015 | PMCID: PMC7756118
Go to all (29) article citations
Data
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
TAM receptors and the regulation of erythropoiesis in mice.
Haematologica, 94(3):326-334, 11 Feb 2009
Cited by: 19 articles | PMID: 19211638 | PMCID: PMC2649353
The residual megakaryocyte and platelet production in c-mpl-deficient mice is not dependent on the actions of interleukin-6, interleukin-11, or leukemia inhibitory factor.
Blood, 95(2):528-534, 01 Jan 2000
Cited by: 32 articles | PMID: 10627458
Mer receptor tyrosine kinase signaling participates in platelet function.
Arterioscler Thromb Vasc Biol, 24(6):1118-1123, 06 May 2004
Cited by: 51 articles | PMID: 15130911
Signalling and functional diversity within the Axl subfamily of receptor tyrosine kinases.
Cytokine Growth Factor Rev, 17(4):295-304, 05 Jun 2006
Cited by: 179 articles | PMID: 16737840
Review